poisar

Stocks · News reference

CORRECTION: Versigent Raises FY2026 Sales Guidance from $9.100B-$9.400B to $9.400B-$9.600B vs $9.286B Est

BenzingaAug 4, 2026, 10:48 AMBenzinga Newsdesk

Versigent (NYSE:VGNT) raises FY2026 sales outlook from $9.100 billion-$9.400 billion to $9.400 billion-$9.600 billion vs $9.286 billion estimate.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 4, 2026, 10:48 AM
Checked
Aug 4, 2026, 10:48 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading